Purple Microport Cardiovascular Profile
Key Indicators
- Authorised Capital ₹ 12.25 Cr
- Paid Up Capital ₹ 1.85 Cr
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 56.52 Cr
- Satisfied Charges ₹ 13.20 Cr
- Revenue Growth 12.01%
- Profit Growth 47.31%
- Ebitda 26.59%
- Net Worth 8.31%
- Total Assets 3.84%
About Purple Microport Cardiovascular
Purple Microport Cardiovascular Private Limited (PMCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 August 2007 and has a history of 17 years and five months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Purple Medical Solutions Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.25 Cr and a paid-up capital of Rs 1.85 Cr.
The company currently has active open charges totaling ₹56.52 Cr. The company has closed loans amounting to ₹13.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Shrivas, Brian Lancelot, and Jonathan Chen serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100MH2007PTC173490
-
Company No.
173490
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Aug 2007
-
Date of AGM
17 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Purple Microport Cardiovascular?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Shrivas
|
Director | 10-Jul-2010 | Current |
|
Brian Lancelot
|
Director | 10-Jul-2010 | Current |
Jonathan Chen
|
Director | 11-Nov-2021 | Current |
Financial Performance of Purple Microport Cardiovascular.
Purple Microport Cardiovascular Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 12.01% increase. The company also saw a substantial improvement in profitability, with a 47.31% increase in profit. The company's net worth moved up by a moderate rise of 8.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Purple Microport Cardiovascular?
In 2024, Purple Microport Cardiovascular had a promoter holding of 63.22% and a public holding of 36.78%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹56.52 Cr
₹13.20 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 34.52 Cr
- Others : 22.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 May 2023 | Others | ₹22.00 Cr | Open |
| 03 Feb 2023 | Axis Bank Limited | ₹1.10 Cr | Open |
| 25 Nov 2020 | Axis Bank Limited | ₹2.19 Cr | Open |
| 03 Apr 2018 | Axis Bank Limited | ₹4.88 Cr | Open |
| 28 Aug 2013 | Axis Bank Limited | ₹21.38 Cr | Open |
How Many Employees Work at Purple Microport Cardiovascular?
Purple Microport Cardiovascular has a workforce of 143 employees as of Dec 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Purple Microport Cardiovascular, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Purple Microport Cardiovascular's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
